Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation¹.
Treatment of these complications can be expensive² yet many are avoidable³, making early identification and intervention key to improving patient outcomes and reducing health costs.

Neuropen^® is the only peripheral neuropathy screening device incorporating both pressure and sharpness tests, giving clinicians a simple, compact solution for testing large and small nerve fibres in the foot.

Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments.

Neuropen^®is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual-purpose, pocket-sized device designed to provide a safe and reliable test.

How Neuropen^® works

• The Neuropen^® is a reusable device that can deliver:
  A 10g pressure test using Neuropen Monofilaments^® to assess any reduction in sensation in the tested area.
• A 40g sharpness test using Neurotips^® single use neurological examination pins, to assess reduced sensation to sharpness/pain in small nerve fibers.